Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer
| Autor: | Marcela G. del Carmen, Christopher K. McCann, Annekathryn Goodman, Elizabeth G. Munro, John O. Schorge, David M. Boruta, Whitfield B. Growdon |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
medicine.medical_specialty medicine.medical_treatment Splenectomy Disease Surgical oncology Overall survival Humans Medicine Aged Neoplasm Staging Aged 80 and over Ovarian Neoplasms Chemotherapy business.industry Middle Aged Prognosis medicine.disease Cystadenocarcinoma Serous Surgery Survival Rate Oncology Cohort Female business Cytoreductive surgery Ovarian cancer Adenocarcinoma Clear Cell Follow-Up Studies |
| Zdroj: | Annals of Surgical Oncology. 18:2912-2918 |
| ISSN: | 1534-4681 1068-9265 |
| DOI: | 10.1245/s10434-011-1661-z |
| Popis: | We sought to examine how splenectomy as part of up-front cytoreductive surgery in ovarian cancer influences the postoperative course and affects survival. We reviewed cases of ovarian cancer diagnosed at Massachusetts General Hospital from 1994 to 2008 and found 44 patients who had a splenectomy as part of their up-front cytoreductive surgery. These were compared to 171 patients who did not undergo splenectomy. We evaluated age at diagnosis, estimated blood loss, percentage of patients whose disease was optimally cytoreduced ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink